Connect with us

Press Releases

Dr. Robert F. Melendez Joins Ocular Science Medical Advisory Board

SoCal biotech’s leadership team expands to more than 30 ophthalmology and optometry key opinion leaders across the U.S.




(PRESS RELEASE) EL SEGUNDO, CA — Dr. Robert F. Melendez MD, CEO/founder of the Juliette Eye Institute in Albuquerque, N.M., is the newest addition to the Ocular Science medical advisory board (MAB). Dr. Melendez, who is also a clinical professor at the University of New Mexico Health Sciences Center and medical correspondent at the ABC-TV affiliate in Albuquerque, is joining a board that establishes strategies that focus on enhanced clinical solutions, products and patient outcomes for Ocular Science and affiliated 503A compounding pharmacy OSRX.

Dr. Melendez, who has performed more than 15,000 cataract and refractive surgeries and was the first in Albuquerque to offer Laser Cataract Surgery (LenSx) and SMILE, started his own business magazine (Ophthalmology Business Minute) and served in the U.S. Air Force as a flight surgeon before separating from the military as a Lieutenant Colonel.

“My practice is predicated on the philosophy that the company behind the product must deliver exemplary customer service,” says Dr. Melendez, who began using compounded ophthalmic medications when he opened the Juliette Eye Institute in 2020. “I was initially a slow adopter of compounded drugs, but I quickly learned it allows me to personalize care for every one of my patients. The Ocular Science and OSRX teams understand people and customers better than anybody else in the industry. I am
eager to lend my insights and expertise to the Ocular Science medical advisory board, a collection of sharp medical leaders who are partnering to improve the patient experience.”

OSRX is a 503A compounding pharmacy that customizes OMNI by OSRX ophthalmic medications that are patient-specific and have been prescribed for surgical vision correction, myopia and glaucoma management. OSRX combines multiple medications into a single bottle to supply patients with simple-to-use, cost-efficient solutions by minimizing dosing complexity.

“Dr. Melendez has established himself as a thought-leader in the industry and, more recently, emerged as a leading voice for compounded medications,” says Eric Garner, Ocular Science chief commercial officer. “Combined with his prowess as a surgeon, Dr. Melendez is an abundantly qualified and welcome addition to our medical advisory board – an elite group which has been instrumental in helping us achieve record financial growth year after year.”




The Best Overall Progressive Lens, Now Powered by AI

Engineered with Behavioral Artificial Intelligence and utilizing new XR-motion™ technology, Varilux XR series goes beyond prescription and eye physiology to consider the patient’s visual behavior and design a progressive lens that respects how
their eyes naturally move.

Varilux XR series comes in two versions, Varilux® XR design and Varilux® XR track. The Varilux XR track lens provides an additional level of personalization by incorporating the exclusive Near Vision Behavior Measurement, providing up to 25% more near vision width3 according to the patient’s need, so patients get the highest level of customization.

Discover Varilux XR series and enjoy instantly sharp vision in motion4 and seamless transitions from near to far.

For more information, visit here.

Promoted Headlines





Get the most important news and business ideas for eyecare professionals every weekday from INVISION.



Most Popular